标题
Intestine-liver crosstalk in Type 2 Diabetes and non-alcoholic fatty liver disease
作者
关键词
Type 2 diabetes, NAFLD, Intestine-liver cross-talk
出版物
METABOLISM-CLINICAL AND EXPERIMENTAL
Volume 123, Issue -, Pages 154844
出版商
Elsevier BV
发表日期
2021-08-01
DOI
10.1016/j.metabol.2021.154844
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Role of the gut microbiota in type 2 diabetes and related diseases
- (2021) Ge Yang et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Muscle fat content is strongly associated with NASH: a longitudinal study in patients with morbid obesity
- (2021) Maxime Nachit et al. JOURNAL OF HEPATOLOGY
- Akkermansia muciniphila Prevents Fatty Liver, Decreases Serum Triglycerides, and Maintains Gut Homeostasis
- (2020) Sejeong Kim et al. APPLIED AND ENVIRONMENTAL MICROBIOLOGY
- Synbiotic Alters Fecal Microbiomes, but not Liver Fat or Fibrosis, in a Randomized Trial of Patients With Non-alcoholic Fatty Liver Disease
- (2020) Eleonora Scorletti et al. GASTROENTEROLOGY
- MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease
- (2020) Mohammed Eslam et al. GASTROENTEROLOGY
- Nidufexor (LMB763), a Novel FXR Modulator for the Treatment of Nonalcoholic Steatohepatitis
- (2020) Donatella Chianelli et al. JOURNAL OF MEDICINAL CHEMISTRY
- The nuclear receptor FXR inhibits Glucagon-Like Peptide-1 secretion in response to microbiota-derived Short-Chain Fatty Acids
- (2020) Sarah Ducastel et al. Scientific Reports
- Allogenic Fecal Microbiota Transplantation in Patients With Nonalcoholic Fatty Liver Disease Improves Abnormal Small Intestinal Permeability
- (2020) Laura Craven et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Bariatric Surgery is Associated With Decreased Progression of Nonalcoholic Fatty Liver Disease to Cirrhosis
- (2020) Keith M. Wirth et al. ANNALS OF SURGERY
- Nonalcoholic Steatohepatitis
- (2020) Adam C. Sheka et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
- (2020) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders
- (2020) Judith Aron-Wisnewsky et al. Nature Reviews Gastroenterology & Hepatology
- The Impact of Bariatric Surgery on Hepatic Function and Predictors of Liver Steatosis and Fibrosis
- (2020) Marta Borges-Canha et al. OBESITY SURGERY
- The Paneth Cell: The Curator and Defender of the Immature Small Intestine
- (2020) Shiloh R. Lueschow et al. Frontiers in Immunology
- Bariatric Surgery Provides Long-term Resolution of Nonalcoholic Steatohepatitis and Regression of Fibrosis
- (2020) Guillaume Lassailly et al. GASTROENTEROLOGY
- Efficacy and Safety of Aldafermin, an Engineered FGF19 Analog, in a Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Nonalcoholic Steatohepatitis
- (2020) Stephen A. Harrison et al. GASTROENTEROLOGY
- A blood-based biomarker panel (NIS4) for non-invasive diagnosis of non-alcoholic steatohepatitis and liver fibrosis: a prospective derivation and global validation study
- (2020) Stephen A Harrison et al. Lancet Gastroenterology & Hepatology
- Effect of dulaglutide on liver fat in patients with type 2 diabetes and NAFLD: randomised controlled trial (D-LIFT trial)
- (2020) Mohammad S. Kuchay et al. DIABETOLOGIA
- Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals
- (2020) Alessandro Mantovani et al. GUT
- Effects of probiotic and prebiotic supplementation on metabolic parameters, liver aminotransferases, and systemic inflammation in nonalcoholic fatty liver disease: A randomized clinical trial
- (2020) Vahideh Behrouz et al. JOURNAL OF FOOD SCIENCE
- Intestinal permeability in human nonalcoholic fatty liver disease: A systematic review and meta‐analysis
- (2020) Toon J. I. De Munck et al. LIVER INTERNATIONAL
- Gut microbiota in human metabolic health and disease
- (2020) Yong Fan et al. NATURE REVIEWS MICROBIOLOGY
- Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes
- (2020) Torsten P. M. Scheithauer et al. Frontiers in Immunology
- Liraglutide or insulin glargine treatments improves hepatic fat in obese patients with type 2 diabetes and nonalcoholic fatty liver disease in twenty-six weeks: A randomized placebo-controlled trial
- (2020) Wen Guo et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Muscle alterations are independently associated with significant fibrosis in patients with nonalcoholic fatty liver disease
- (2020) Yun‐Cheng Hsieh et al. LIVER INTERNATIONAL
- Inulin Exerts Beneficial Effects on Non-Alcoholic Fatty Liver Disease via Modulating gut Microbiome and Suppressing the Lipopolysaccharide-Toll-Like Receptor 4-Mψ-Nuclear Factor-κB-Nod-Like Receptor Protein 3 Pathway via gut-Liver Axis in Mice
- (2020) Ting Bao et al. Frontiers in Pharmacology
- Intestinal TGR5 agonism improves hepatic steatosis and insulin sensitivity in Western diet-fed mice
- (2019) Patricia D. Finn et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Metabolic (Bariatric and Nonbariatric) Surgery for Type 2 Diabetes: A Personal Perspective Review
- (2019) Henry Buchwald et al. DIABETES CARE
- Randomized trial comparing effects of weight loss by liraglutide with lifestyle modification in non‐alcoholic fatty liver disease
- (2019) Joan Khoo et al. LIVER INTERNATIONAL
- NGM 282 Improves Liver Fibrosis and Histology in 12 Weeks in Patients with Nonalcoholic Steatohepatitis
- (2019) Stephen A. Harrison et al. HEPATOLOGY
- Bile acid alterations in nonalcoholic fatty liver disease, obesity, insulin resistance and type 2 diabetes
- (2019) Oscar Chávez-Talavera et al. CURRENT OPINION IN LIPIDOLOGY
- Leaky gut: mechanisms, measurement and clinical implications in humans
- (2019) Michael Camilleri GUT
- The Global Epidemiology of NAFLD and NASH in Patients with type 2 diabetes: A Systematic Review and Meta-analysis
- (2019) Zobair M. Younossi et al. JOURNAL OF HEPATOLOGY
- Non‐Alcoholic Fatty Liver Disease, Liver Fibrosis Score and Cognitive Function in Middle‐Aged Adults: The Framingham Study
- (2019) Galit Weinstein et al. LIVER INTERNATIONAL
- Randomized, Double-blind, Placebo-controlled Study of a Multispecies Probiotic Mixture in Nonalcoholic Fatty Liver Disease
- (2019) Sang Bong Ahn et al. Scientific Reports
- Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development
- (2019) Juliette Mouries et al. JOURNAL OF HEPATOLOGY
- CD8+T CELLS REGULATE LIVER INJURY IN OBESITY-RELATED NONALCOHOLIC FATTY LIVER DISEASE
- (2019) Denitra A Breuer et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Screening for non-alcoholic fatty liver disease using liver stiffness measurement and its association with chronic kidney disease and cardiovascular complications in patients with type 2 diabetes
- (2019) A. Mantovani et al. DIABETES & METABOLISM
- Sarcopenia is associated with non-alcoholic fatty liver disease in men with type 2 diabetes
- (2019) D.H. Seo et al. DIABETES & METABOLISM
- Gut-associated IgA+ immune cells regulate obesity-related insulin resistance
- (2019) Helen Luck et al. Nature Communications
- Increased liver localization of lipopolysaccharides in human and experimental non‐alcoholic fatty liver disease
- (2019) Guido Carpino et al. HEPATOLOGY
- Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
- (2019) Zobair M Younossi et al. LANCET
- Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism
- (2018) Preeti Pathak et al. HEPATOLOGY
- Lactobacillus acidophilus NS1 attenuates diet-induced obesity and fatty liver
- (2018) Sung-Soo Park et al. JOURNAL OF ENDOCRINOLOGY
- INT-767 prevents NASH and promotes visceral fat brown adipogenesis and mitochondrial function
- (2018) Paolo Comeglio et al. JOURNAL OF ENDOCRINOLOGY
- Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?
- (2018) Amedeo Lonardo et al. JOURNAL OF HEPATOLOGY
- NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
- (2018) Stephen A Harrison et al. LANCET
- Expert consensus document: Clinical and molecular diagnosis, screening and management of Beckwith–Wiedemann syndrome: an international consensus statement
- (2018) Frédéric Brioude et al. Nature Reviews Endocrinology
- Nonalcoholic fatty liver disease in patients with different baseline glucose status undergoing bariatric surgery: analysis of intraoperative liver biopsies and literature review
- (2018) Katia P. Souto et al. Surgery for Obesity and Related Diseases
- Intestinal Intraepithelial Lymphocytes: Sentinels of the Mucosal Barrier
- (2018) Danyvid Olivares-Villagómez et al. TRENDS IN IMMUNOLOGY
- INT-767 improves histopathological features in a diet-induced ob/ob mouse model of biopsy-confirmed non-alcoholic steatohepatitis
- (2018) Jonathan D Roth et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Association of Nonalcoholic Fatty Liver Disease With Lower Brain Volume in Healthy Middle-aged Adults in the Framingham Study
- (2018) Galit Weinstein et al. JAMA Neurology
- Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables
- (2018) Emma Ahlqvist et al. Lancet Diabetes & Endocrinology
- Innate Lymphoid Cells: 10 Years On
- (2018) Eric Vivier et al. CELL
- Self-Maintaining Gut Macrophages Are Essential for Intestinal Homeostasis
- (2018) Sebastiaan De Schepper et al. CELL
- Rifaximin in nonalcoholic fatty liver disease
- (2018) Ahmed Abdel-Razik et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Small metabolites, possible big changes: a microbiota-centered view of non-alcoholic fatty liver disease
- (2018) Huikuan Chu et al. GUT
- Apoptosis and necroptosis in the liver: a matter of life and death
- (2018) Robert F. Schwabe et al. Nature Reviews Gastroenterology & Hepatology
- Mechanisms of Insulin Action and Insulin Resistance
- (2018) Max C. Petersen et al. PHYSIOLOGICAL REVIEWS
- Serum bile acid patterns are associated with the presence of NAFLD in twins, and dose-dependent changes with increase in fibrosis stage in patients with biopsy-proven NAFLD
- (2018) Cyrielle Caussy et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Microbially Produced Imidazole Propionate Impairs Insulin Signaling through mTORC1
- (2018) Ara Koh et al. CELL
- Liraglutide, sitagliptin and insulin glargine added to metformin: the effect on body weight and intrahepatic lipid in patients with type 2 diabetes mellitus and NAFLD
- (2018) Jinhua Yan et al. HEPATOLOGY
- Bile Acid Control of Metabolism and Inflammation in Obesity, Type 2 Diabetes, Dyslipidemia, and Nonalcoholic Fatty Liver Disease
- (2017) Oscar Chávez-Talavera et al. GASTROENTEROLOGY
- Fibroblast growth factor 15/19 (FGF15/19) protects from diet-induced hepatic steatosis: development of an FGF19-based chimeric molecule to promote fatty liver regeneration
- (2017) Gloria Alvarez-Sola et al. GUT
- Human Secretory IgM Emerges from Plasma Cells Clonally Related to Gut Memory B Cells and Targets Highly Diverse Commensals
- (2017) Giuliana Magri et al. IMMUNITY
- Immunologic impact of the intestine in metabolic disease
- (2017) Daniel A. Winer et al. JOURNAL OF CLINICAL INVESTIGATION
- Treatment of NAFLD with diet, physical activity and exercise
- (2017) Manuel Romero-Gómez et al. JOURNAL OF HEPATOLOGY
- Discovery of Tropifexor (LJN452), a Highly Potent Non-bile Acid FXR Agonist for the Treatment of Cholestatic Liver Diseases and Nonalcoholic Steatohepatitis (NASH)
- (2017) David C. Tully et al. JOURNAL OF MEDICINAL CHEMISTRY
- High prevalence of apolipoprotein B dyslipoproteinemias in non-alcoholic fatty liver disease: The lifelines cohort study
- (2017) Karlijn J. Nass et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics
- (2017) Glenn R. Gibson et al. Nature Reviews Gastroenterology & Hepatology
- Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier
- (2017) Da Zhou et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Nonalcoholic Fatty Liver Disease Is Exacerbated in High-Fat Diet-Fed Gnotobiotic Mice by Colonization with the Gut Microbiota from Patients with Nonalcoholic Steatohepatitis
- (2017) Chien-Chao Chiu et al. Nutrients
- Randomized trial comparing the effects of gliclazide, liraglutide, and metformin on diabetes with non-alcoholic fatty liver disease
- (2017) Wenhuan Feng et al. Journal of Diabetes
- Next-Generation Beneficial Microbes: The Case of Akkermansia muciniphila
- (2017) Patrice D. Cani et al. Frontiers in Microbiology
- Pathophysiology and Mechanisms of Nonalcoholic Fatty Liver Disease
- (2016) Joel T. Haas et al. Annual Review of Physiology
- From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites
- (2016) Ara Koh et al. CELL
- Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism
- (2016) Annika Wahlström et al. Cell Metabolism
- Colonic Pro-inflammatory Macrophages Cause Insulin Resistance in an Intestinal Ccl2/Ccr2-Dependent Manner
- (2016) Yoshinaga Kawano et al. Cell Metabolism
- Obeticholic Acid: First Global Approval
- (2016) A. Markham et al. DRUGS
- Loss of Junctional Adhesion Molecule A Promotes Severe Steatohepatitis in Mice on a Diet High in Saturated Fat, Fructose, and Cholesterol
- (2016) Khalidur Rahman et al. GASTROENTEROLOGY
- Signalling via the osteopontin and high mobility group box-1 axis drives the fibrogenic response to liver injury
- (2016) Elena Arriazu et al. GUT
- Changes in blood microbiota profiles associated with liver fibrosis in obese patients: A pilot analysis
- (2016) Benjamin Lelouvier et al. HEPATOLOGY
- What Makes MAITs Wait?
- (2016) Mark A. Exley IMMUNITY
- Peyer's patches: organizing B-cell responses at the intestinal frontier
- (2016) Andrea Reboldi et al. IMMUNOLOGICAL REVIEWS
- Postprandial Plasma Concentrations of Individual Bile Acids and FGF-19 in Patients With Type 2 Diabetes
- (2016) David P. Sonne et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial
- (2016) Jeffrey Cui et al. JOURNAL OF HEPATOLOGY
- Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease
- (2016) Panu K. Luukkonen et al. JOURNAL OF HEPATOLOGY
- Glutamine supplementation attenuates ethanol-induced disruption of apical junctional complexes in colonic epithelium and ameliorates gut barrier dysfunction and fatty liver in mice
- (2016) Kamaljit K. Chaudhry et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
- (2016) Matthew James Armstrong et al. LANCET
- Diet–microbiota interactions as moderators of human metabolism
- (2016) Justin L. Sonnenburg et al. NATURE
- Gut microbiome–derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease
- (2016) Nathan D Mathewson et al. NATURE IMMUNOLOGY
- NAFLD and diabetes mellitus
- (2016) Herbert Tilg et al. Nature Reviews Gastroenterology & Hepatology
- Antibiotic perturbation of the murine gut microbiome enhances the adiposity, insulin resistance, and liver disease associated with high-fat diet
- (2016) Douglas Mahana et al. Genome Medicine
- Jejunal T Cell Inflammation in Human Obesity Correlates with Decreased Enterocyte Insulin Signaling
- (2015) Milena Monteiro-Sepulveda et al. Cell Metabolism
- Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients
- (2015) Guillaume Lassailly et al. GASTROENTEROLOGY
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
- (2015) Brent A Neuschwander-Tetri et al. LANCET
- Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells
- (2015) Mohamed-Sami Trabelsi et al. Nature Communications
- Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction
- (2015) Changtao Jiang et al. Nature Communications
- Randomised clinical trial: the beneficial effects of VSL#3 in obese children with non-alcoholic steatohepatitis
- (2014) A. Alisi et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study
- (2014) Tannaz Eslamparast et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Intestinal Lipid Handling
- (2014) Alain Veilleux et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- The mucus and mucins of the goblet cells and enterocytes provide the first defense line of the gastrointestinal tract and interact with the immune system
- (2014) Thaher Pelaseyed et al. IMMUNOLOGICAL REVIEWS
- Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease
- (2014) Changtao Jiang et al. JOURNAL OF CLINICAL INVESTIGATION
- The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes
- (2014) Rachel J. Perry et al. NATURE
- The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic
- (2014) Colin Hill et al. Nature Reviews Gastroenterology & Hepatology
- Ectopic Fat in Insulin Resistance, Dyslipidemia, and Cardiometabolic Disease
- (2014) Gerald I. Shulman NEW ENGLAND JOURNAL OF MEDICINE
- Increased circulating zonulin in children with biopsy-proven nonalcoholic fatty liver disease
- (2014) Lucia Pacifico WORLD JOURNAL OF GASTROENTEROLOGY
- Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
- (2013) Sunder Mudaliar et al. GASTROENTEROLOGY
- Community-based lifestyle modification programme for non-alcoholic fatty liver disease: A randomized controlled trial
- (2013) Vincent Wai-Sun Wong et al. JOURNAL OF HEPATOLOGY
- Richness of human gut microbiome correlates with metabolic markers
- (2013) Emmanuelle Le Chatelier et al. NATURE
- Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells
- (2013) Yukihiro Furusawa et al. NATURE
- Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
- (2013) Nicholas Arpaia et al. NATURE
- Gut metagenome in European women with normal, impaired and diabetic glucose control
- (2013) Fredrik H. Karlsson et al. NATURE
- Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
- (2013) Els van Nood et al. NEW ENGLAND JOURNAL OF MEDICINE
- Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity
- (2013) Fei Li et al. Nature Communications
- Absence of Acute Inhibitory Effect of Insulin on Chylomicron Production in Type 2 Diabetes
- (2012) Juan-Patricio Nogueira et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Transfer of Intestinal Microbiota From Lean Donors Increases Insulin Sensitivity in Individuals With Metabolic Syndrome
- (2012) Anne Vrieze et al. GASTROENTEROLOGY
- Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: A connection between endogenous alcohol and NASH
- (2012) Lixin Zhu et al. HEPATOLOGY
- A metagenome-wide association study of gut microbiota in type 2 diabetes
- (2012) Junjie Qin et al. NATURE
- Farnesoid X Receptor Deficiency Improves Glucose Homeostasis in Mouse Models of Obesity
- (2011) J. Prawitt et al. DIABETES
- The G-Protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor kappa light-chain enhancer of activated B cells (NF-κB) in mice
- (2011) Yan-Dong Wang et al. HEPATOLOGY
- Intestinal Tolerance Requires Gut Homing and Expansion of FoxP3+ Regulatory T Cells in the Lamina Propria
- (2011) Usriansyah Hadis et al. IMMUNITY
- Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid–induced ceramide biosynthesis in mice
- (2011) William L. Holland et al. JOURNAL OF CLINICAL INVESTIGATION
- Ceramides as modulators of cellular and whole-body metabolism
- (2011) Benjamin T. Bikman et al. JOURNAL OF CLINICAL INVESTIGATION
- PKCδ regulates hepatic insulin sensitivity and hepatosteatosis in mice and humans
- (2011) Olivier Bezy et al. JOURNAL OF CLINICAL INVESTIGATION
- Serum interleukin 1 receptor antagonist as an independent marker of non-alcoholic steatohepatitis in humans
- (2011) Jussi Pihlajamäki et al. JOURNAL OF HEPATOLOGY
- Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
- (2011) Zeneng Wang et al. NATURE
- Improved glycemic control with colesevelam treatment in patients with type 2 diabetes is not directly associated with changes in bile acid metabolism
- (2010) Gemma Brufau et al. HEPATOLOGY
- Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
- (2010) Giovanni Targher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease
- (2009) Luca Miele et al. HEPATOLOGY
- Changes in Gut Microbiota Control Metabolic Endotoxemia-Induced Inflammation in High-Fat Diet-Induced Obesity and Diabetes in Mice
- (2008) P. D. Cani et al. DIABETES
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started